Pharmaceutical regulations to be streamlined

The government will revise pharmaceutical regulations on drug-related license system, the Korea Food and Drug Administration said recently.

The changes, which were outlined in the task force meeting of government officials from the health ministry and KFDA on July 19, include improvement of the license system by separating product license from manufacturing license, introduction of product l...